氧气驱动雾化氨溴索治疗小儿毛细支气管炎的临床分析

Clinical analysis of oxygen-driven atomizing ambroxol in the treatment of children with capillary bronchial pneumonia

目的探讨氧气驱动雾化氨溴索治疗小儿毛细支气管炎的疗效。方法将2008年2月～2012年4月本科收治的126例小儿毛细支气管炎患者随机分为实验组(n=63)与对照组(n=63),对照组患者接受常规治疗,实验组患者接受常规治疗联合氧气驱动雾化氨溴索。比较两组的临床疗效及咳嗽消失时间、湿啰音消失时间、哮鸣音消失时间、住院时间。结果实验组患者咳嗽消失时间、湿啰音消失时间、哮鸣音消失时间、住院时间显著短于对照组,两组比较差异有统计学意义(P<0.05)。实验组治疗效果显著优于对照组,两组比较差异有统计学意义(P<0.05)。结论氧气驱动雾化氨溴索可加速小儿毛细支气管炎的恢复速度,并提高其疗效。

Objective To study the therapeutic efficacy of children with capillary bronchial pneumonia treated with oxygen-driven atomizing ambroxol. Methods One hundred and twenty-six cases of children with capillary bronchial pneumonia were admitted into our hospital from February 2008 to April 2012 and divided into experimental group （n = 63） and control group （n = 63）, and control group was received conventional treatment, while experimental group was given conventional treatment combined with oxygen-driven atomizing ambroxol. The clinical efficacy and cough disappeared time, moist rales disappeared time, wheezes disappeared time between two groups were compared. Results The cough disappeared time, moist rales disappeared time, wheezes disappeared time of experimental group were significantly shorter than those of control group, respectively （P 〈 0.05）. The therapeutic efficacy of experimental group were significantly better than that of control group （P 〈 0.05）. Conclusion The oxygen-driven atomizing ambroxol in the treatment of children with capillary bronchial pneumonia can accelerate the speeding of recovery, and improve the efficacy.